Becton Dickinson Comprehensive Income 2010-2024 | BDX
Becton Dickinson comprehensive income from 2010 to 2024. Comprehensive income can be defined as the change in net assets of a business enterprise during a period from transactions and other events and circumstances from nonowner sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.
- Becton Dickinson comprehensive income for the quarter ending June 30, 2024 was $-1.579B, a 4.78% increase year-over-year.
- Becton Dickinson comprehensive income for 2023 was $-1.548B, a 4.03% increase from 2022.
- Becton Dickinson comprehensive income for 2022 was $-1.488B, a 28.74% decline from 2021.
- Becton Dickinson comprehensive income for 2021 was $-2.088B, a 18.05% decline from 2020.
Becton Dickinson Annual Comprehensive Income
(Millions of US $) |
| 2023 |
$-1,548 |
| 2022 |
$-1,488 |
| 2021 |
$-2,088 |
| 2020 |
$-2,548 |
| 2019 |
$-2,283 |
| 2018 |
$-1,909 |
| 2017 |
$-1,723 |
| 2016 |
$-1,929 |
| 2015 |
$-1,738 |
| 2014 |
$-1,001 |
| 2013 |
$-516 |
| 2012 |
$-802 |
| 2011 |
$-670 |
| 2010 |
$-458 |
| 2009 |
$-373 |
Becton Dickinson Quarterly Comprehensive Income
(Millions of US $) |
| 2024-06-30 |
$-1,579 |
| 2024-03-31 |
$-1,535 |
| 2023-12-31 |
$-1,515 |
| 2023-09-30 |
$-1,548 |
| 2023-06-30 |
$-1,507 |
| 2023-03-31 |
$-1,575 |
| 2022-12-31 |
$-1,559 |
| 2022-09-30 |
$-1,488 |
| 2022-06-30 |
$-1,660 |
| 2022-03-31 |
$-1,910 |
| 2021-12-31 |
$-2,043 |
| 2021-09-30 |
$-2,088 |
| 2021-06-30 |
$-2,330 |
| 2021-03-31 |
$-2,329 |
| 2020-12-31 |
$-2,414 |
| 2020-09-30 |
$-2,548 |
| 2020-06-30 |
$-2,367 |
| 2020-03-31 |
$-2,419 |
| 2019-12-31 |
$-2,202 |
| 2019-09-30 |
$-2,283 |
| 2019-06-30 |
$-1,897 |
| 2019-03-31 |
$-1,839 |
| 2018-12-31 |
$-1,927 |
| 2018-09-30 |
$-1,909 |
| 2018-06-30 |
$-1,902 |
| 2018-03-31 |
$-1,704 |
| 2017-12-31 |
$-1,740 |
| 2017-09-30 |
$-1,723 |
| 2017-06-30 |
$-1,923 |
| 2017-03-31 |
$-2,009 |
| 2016-12-31 |
$-2,162 |
| 2016-09-30 |
$-1,929 |
| 2016-06-30 |
$-1,605 |
| 2016-03-31 |
$-1,647 |
| 2015-12-31 |
$-1,840 |
| 2015-09-30 |
$-1,738 |
| 2015-06-30 |
$-1,535 |
| 2015-03-31 |
$-1,623 |
| 2014-12-31 |
$-1,139 |
| 2014-09-30 |
$-1,001 |
| 2014-06-30 |
$-457 |
| 2014-03-31 |
$-455 |
| 2013-12-31 |
$-500 |
| 2013-09-30 |
$-516 |
| 2013-06-30 |
$-864 |
| 2013-03-31 |
$-803 |
| 2012-12-31 |
$-746 |
| 2012-09-30 |
$-802 |
| 2012-06-30 |
$-706 |
| 2012-03-31 |
$-453 |
| 2011-12-31 |
$-573 |
| 2011-09-30 |
$-670 |
| 2011-06-30 |
$-198 |
| 2011-03-31 |
$-291 |
| 2010-12-31 |
$-477 |
| 2010-09-30 |
$-458 |
| 2010-06-30 |
$-598 |
| 2010-03-31 |
$-460 |
| 2009-12-31 |
$-338 |
| 2009-09-30 |
$-373 |
| 2009-06-30 |
$-220 |
| 2009-03-31 |
$-360 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$66.939B |
$19.372B |
|
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
|
